Introduction
============

Building on the groundbreaking work of McClintock \[[@B1]\] and numerous others \[[@B2]-[@B14]\], we further advanced the proposition of transposable elements (TEs) as powerful facilitators of evolution \[[@B15]\] and now formalise this into \'The TE-Thrust hypothesis\'. In this paper, we present much specific evidence in support of this hypothesis, which we suggest may have great explanatory power. We focus mainly on the well-studied higher primate (monkey, ape and human) lineages. We emphasize the part played by the retro-TEs, especially the primate-specific non-autonomous Alu short interspersed element (SINE), together with its requisite autonomous partner long interspersed element (LINE)-1 or L1 (Figure [1A](#F1){ref-type="fig"}). In addition, both ancient and recent endogenizations of exogenous retroviruses (endogenous retroviruses (ERVs)/solo long terminal repeats (sLTRs) have been very important in primate evolution (Figure [1A](#F1){ref-type="fig"}). The Alu element has been particularly instrumental in the evolution of primates by TE-Thrust. This suggests that, at least in some mammalian lineages, specific SINE-LINE pairs have a large influence on the trajectory and extent of evolution on the different clades within that lineage.

![**Summary of the effect of TEs on primate evolution**. **(A)**Transposable elements (TEs) implicated in the generation of primate-specific traits. **(B)**Types of events mediated by TEs underlying primate-specific traits. Passive events entail TE-mediated duplications, inversions or deletions. **(C)**Aspects of primate phenotype affected by TEs. Based on the published data shown in Tables 3 to 6.](1759-8753-2-8-1){#F1}

The TE-Thrust Hypothesis
========================

The ubiquitous, very diverse, and mostly extremely ancient TEs are powerful facilitators of genome evolution, and therefore of phenotypic diversity. TE-Thrust acts to build, sculpt and reformat genomes, either actively by TE transposition and integration (active TE-Thrust), or passively, because after integration, TEs become dispersed homologous sequences that facilitate ectopic DNA recombination (passive TE-Thrust). TEs can cause very significant and/or complex coding, splicing, regulatory and karyotypic changes to genomes, resulting in phenotypes that can adapt well to biotic or environmental challenges, and can often invade new ecological niches. TEs are usually strongly controlled in the soma, where they can be damaging \[[@B16],[@B17]\], but they are allowed some limited mobility in the germline and early embryo \[[@B18]-[@B20]\], where, although they can occasionally be harmful, they can also cause beneficial changes that can become fixed in a population, benefiting the existing lineage, and sometimes generating new lineages.

There is generally no Darwinian selection for individual TEs or TE families, although there may be exceptions, such as the primate-specific Alu SINEs in gene-rich areas \[[@B21],[@B22]\]. Instead, according to the TE-Thrust hypothesis, there is differential survival of those lineages that contain or can acquire suitable germline repertoires of TEs, as these lineages can more readily adapt to environmental or ecological changes, and can potentially undergo, mostly intermittently, fecund radiations. We hypothesize that lineages lacking a suitable repertoire of TEs are, if all else is equal, are liable to stasis, possibly becoming \'living fossils\' or even becoming extinct.

TE activity is usually intermittent \[[@B23]-[@B27]\], with periodic bursts of transposition due to interplay between various cellular controls, various stresses, *de novo*syntheses, *de novo*modifications, new infiltrations of DNA-TEs (by horizontal transfer), or new endogenizations of retroviruses. However, the vast majority of viable TEs usually undergo slow mutational decay and become non-viable (incapable of activity), although some superfamilies have remained active for more than 100 Myr. Episodic TE activity and inactivity, together with differential survival of lineages, suggests an explanation for punctuated equilibrium, evolutionary stasis, fecund lineages and adaptive radiations, all found in the fossil record, and for extant \'fossil species\' \[[@B15],[@B28]\].

TE-Thrust is expected to be optimal in lineages in which TEs are active and/or those that possess a high content of homogeneous TEs, both of which can promote genomic dynamism \[[@B15]\]. We hypothesize four main modes of TE-Thrust (Table [1](#T1){ref-type="table"}), but as these are extremes of continuums, many intermediate modes are possible.

###### 

Hypothesized major modes of transposable element (TE)-thrust

  Mode   TE activity                        TE homogeneity   TE population size   Evolutionary outcome                 Type of TE thrust
  ------ ---------------------------------- ---------------- -------------------- ------------------------------------ --------------------
  1      Viable and intermittently active   Heterogeneous    Large                Stasis with punctuation events       Active
                                                             Small                Stasis with punctuation events       Active
  2      Viable and intermittently active   Homogeneous      Large                Gradualism with punctuation events   Active and passive
                                                             Small                Stasis with punctuation events       Active
  3      Non-viable/Inactive                Heterogeneous    Large                Stasis^a,b^                          Minimal^c^
                                                             Small                Stasis^a,b^                          Minimal^c^
  4      Non-viable/Inactive                Homogeneous      Large                Gradualism^a^                        Passive^c^
                                                             Small                Stasis^a,b^                          Minimal^c^

^a^Unless new infiltrations or reactivation of TEs occur.

^b^Fossil taxa are a possible outcome of prolonged stasis.

^c^Inactive/non-viable TEs can be exapted in a delayed fashion, which could cause some resumption of active TE-Thrust.

• Mode 1: periodically active heterogeneous populations of TEs result in stasis with the potential for intermittent punctuation events.

• Mode 2: periodically active homogenous populations of TEs result in: 1) gradualism as a result of ectopic recombination, if the TE population is large, with the potential for periodic punctuation events, or 2) stasis with the potential for periodic punctuation events if the TE population is small.

• Mode 3: non-viable heterogeneous populations of TEs, in the absence of new infiltrations, result in prolonged stasis, which can sometimes result in extinctions and/or \'living fossils\'.

• Mode 4: non-viable homogenous populations of TEs, in the absence of new infiltrations, can result in: 1) gradualism as a result of ectopic recombination, if the TE population is large or 2) stasis if the TE population is small.

These modes of TE-Thrust are in agreement with the findings of palaeontologists \[[@B29]\] and some evolutionary biologists \[[@B30]\] that punctuated equilibrium is the most common mode of evolution, but that gradualism and stasis also occur. Many extant \'living fossils\' are also known.

We acknowledge that TE-Thrust acts by enhancing evolutionary potential, and whether that potential is actually realized is heavily influenced by environmental, ecological and other factors. Moreover, there are many other \'engines\' of evolution besides TE-Thrust, such as point mutation, simple sequence repeats, endosymbiosis, epigenetic modification and whole-genome duplication \[[@B31]-[@B35]\], among others. These often complement TE-Thrust; for example, point mutations can endow duplicated or retrotransposed genes with new functions \[[@B36],[@B37]\]. There may also be other, as yet unknown, or hypothesized but unconfirmed, \'engines\' of evolution.

Higher primate genomes are very suited to TE-Thrust as they possess large homogeneous populations of TEs
========================================================================================================

Human and other extant higher primate genomes are well endowed with a relatively small repertoire of TEs (Table [2](#T2){ref-type="table"}). These TEs, which have been extensively implicated in engineering primate-specific traits (Table [3](#T3){ref-type="table"}; Table [4](#T4){ref-type="table"}; Table [5](#T5){ref-type="table"}; Table [6](#T6){ref-type="table"}), are largely relics of an evolutionary history marked by periodic bursts of TE activity \[[@B25],[@B38],[@B39]\]. TE activity is presently much reduced, but extant simian lineage genomes remain well suited for passive TE-Thrust, with just two elements, Alu and L1, accounting for over 60% of the total TE DNA sequence \[[@B21],[@B40],[@B41]\]. In humans, there are 10 times as many mostly homogeneous class I retro-TEs as there are very heterogeneous class II DNA-TEs \[[@B21]\]. Only L1, Alu, SVA (SINE-R, variable number of tandem repeats (VNTR), Alu) and possibly some ERVs, remain active in humans \[[@B42]\].

###### 

Summary of the major transposable elements (TEs) found in humans

                      Family                      Percentage of genome   Number in genome   Average length, bp   Maximum length, kb   Viable   Potentially autonomous
  ------------------- --------------------------- ---------------------- ------------------ -------------------- -------------------- -------- ---------------------------------
  Type I: retro-TEs   LTR^a^/ERV^b^               8.3                    443,000            510                  10                   No       Yes (via reverse transcriptase)
                      LINE1^c^                    16.9                   516,000            900                  6                    Some     Yes (via reverse transcriptase)
                      LINE2                       3.2                    315,000            280                  5                    No       Yes (via reverse transcriptase)
                      Alu SINE^d^                 10.6                   1,090,000          270                  0.3                  Yes      No
                      MIR^e^SINE                  2.2                    393,000            150                  0.26                 No       No
                      SVA^f^SINE-like composite   0.2                    3,000              1,400                3                    Yes      No
  Type II: DNA-TEs    Many                        2.8                    294,000            260                  3                    No       Some (via transposase)

^a^LTR = long terminal repeat

^b^ERV = endogenous retrovirus

^c^LINE = long interspersed nuclear element

^d^SINE = short interspersed nuclear element

^e^MIR = mammalian-wide interspersed repeat

^f^SVA = SINE-VNTR-Alu

###### 

Specific examples of transposable elements (TEs) implicated in primate-specific traits: brain and sensory

  TE generated trait                    Gene affected   Gene function                                              TE responsible   Distribution^a^         Type of event        Effect                  Tissue expression          Type of TE-Thrust   Reference
  ------------------------------------- --------------- ---------------------------------------------------------- ---------------- ----------------------- -------------------- ----------------------- -------------------------- ------------------- -------------------------------------------
                                        *snaRs*         Cell growth and translational regulation                   Alu              Afr. great ape/ human   Domestication        Novel genes             Brain, testis              Active              Parrott and Mathews, 2009 \[[@B105]\]
                                        *BCYRN1*        Translational regulation of dendritic proteins             Alu              Simian                  Domestication        Novel gene              Brain                      Active              Watson and Sutcliffe, 1987 \[[@B106]\]
                                        *FLJ33706*      Unknown                                                    Alu              Human                   Domestication        Novel gene              Brain                      Active              Li *et al.*, 2010 \[[@B107]\]
  Neuronal stability?                   *SETMAR*        DNA repair and replication                                 Hsmar1           Simian                  Exonization          Novel fusion gene       Brain, various             Active              Cordaux *et al.*, 2006 \[[@B108]\]
                                        *Survivin*      Anti-apoptotic/brain development                           Alu              Ape                     Exonization          Novel isoform           Brain, spleen              Active              Mola *et al.*, 2007 \[[@B109]\]
                                        *ADARB1*        RNA editing/neurotransmitter receptor diversity            Alu              \>Human                 Exonization          Novel isoform           Brain, various             Active              Lai *et al.*, 1997 \[[@B110]\]
                                        *CHRNA1*        Synaptic transmission                                      MIR^b^           Great ape               Exonization          Novel isoform           Neuromuscular              Active              Krull *et al.*, 2007 \[[@B47]\]
                                        *ASMT*          Melatonin synthesis                                        LINE-1^c^        \>Human                 Exonization          Novel isoform           Pineal gland               Active              Rodriguez *et al.*, 1994 \[[@B111]\]
                                        *CHRNA3*        Synaptic transmission                                      Alu              Great ape               Regulatory           Major promoter          Nervous system             Active              Fornasari *et al.*, 1997 \[[@B112]\]
                                        *CHRNA6*        Synaptic transmission                                      Alu              \>Human                 Regulatory           Negative regulation     Brain                      Active              Ebihara *et al.*, 2002 \[[@B113]\]
                                        *NAIP*          Anti-apoptosis (motor neuron)                              Alu              \>Human                 Regulatory           Alternative promoters   CNS, various               Active              Romanish *et al.*, 2009 \[[@B114]\]
                                        *CNTNAP4*       Cell recognition/adhesion                                  ERV^d^           \>Human                 Regulatory           Alternative promoter    Brain, testis              Active              van de Lagemaat *et al.*, 2003 \[[@B73]\]
                                        *CCRK*          Cell cycle-related kinase                                  Alu              Simian                  Regulatory           CpG island              Brain                      Active              Farcas *et al.*, 2009 \[[@B86]\]
  Enhanced cognitive capacity/memory?   *GLUD2*         Neurotransmitter recycling                                 Unknown          Ape                     Retrotransposition   Novel gene              Brain                      Active              Burki and Kaessmann, 2004 \[[@B37]\]
  Altered auditory perception?          *CHRNA9*        Cochlea hair development/ modulation of auditory stimuli   Alu              Human                   Deletion             Exon loss               Cochlea, sensory ganglia   Passive             Sen *et al.*, 2006 \[[@B62]\]
  Trichromatic colour vision            *OPN1LW*        Cone photoreceptor                                         Alu              Old World primate       Duplication          Novel gene              Retina                     Passive             Dulai *et al.*, 1999 \[[@B36]\]

^a^\> = Maximum known distribution.

^b^MIR = mammalian-wide interspersed repeat

^c^LINE = long interspersed nuclear element

^d^ERV = endogenous retrovirus

###### 

Specific examples of transposable elements (TEs) implicated in primate-specific traits: reproduction and development

  TE generated trait                                      Gene affected     Gene function                                                                                                  TE responsible      Distribution^a^     Type of event        Effect                     Tissue expression                   Type of TE-Thrust   Reference
  ------------------------------------------------------- ----------------- -------------------------------------------------------------------------------------------------------------- ------------------- ------------------- -------------------- -------------------------- ----------------------------------- ------------------- -------------------------------------------
  Placental morphogenesis                                 *Syncytin-1*      Trophoblast cell fusion                                                                                        ERV^b^              Ape                 Domestication        Novel gene                 Placenta                            Active              Mi *et al.*, 2000 \[[@B92]\]
  Placental morphogenesis                                 *Syncytin-2*      Trophoblast cell fusion                                                                                        ERV                 Simian              Domestication        Novel gene                 Placenta                            Active              Blaise *et al.*, 2003 \[[@B93]\]
                                                          *HERVV1*          Unknown                                                                                                        ERV                 Simian              Domestication        Novel gene                 Placenta                            Active              Kjeldbjerg *et al.*, 2008 \[[@B115]\]
                                                          *HERVV2*          Unknown                                                                                                        ERV                 Simian              Domestication        Novel gene                 Placenta                            Active              Kjeldbjerg *et al.*, 2008 \[[@B115]\]
                                                          *ERV3*            Development and differentiation?                                                                               ERV                 Old World primate   Domestication        Novel gene                 Placenta, various                   Active              Larsson *et al.*, 1994 \[[@B116]\]
                                                          *DNMT1*           DNA methylation                                                                                                Alu                 \>Afr. great ape    Exonization          Novel isoform              Fetal, various                      Active              Hsu *et al.*, 1999 \[[@B117]\]
                                                          *LEPR*            Leptin receptor                                                                                                SVA                 Human               Exonization          Novel isoform              Fetal liver                         Active              Damert *et al.*, 2004 \[[@B118]\]
                                                          *IL22RA2*         Regulation of inflammatory responses/interleukin-22 decoy receptor                                             LTR^c^              Great ape           Exonization          Novel isoform              Placenta                            Active              Piriyapongsa *et al.*, 2007 \[[@B119]\]
                                                          *PPHLN1*          Epithelial differentiation/nervous-system development                                                          ERV/Alu/LINE-1^d^   Ape                 Exonization          Novel isoforms             Fetal, various                      Active              Huh *et al.*, 2006 \[[@B120]\]
                                                          *CGB1/2*          Chorionic gonadotropin                                                                                         Alu (snaR-G1/2)     Afr. great ape      Regulatory           Major promoter             Testis                              Active              Parrott and Mathews, 2009 \[[@B105]\]
                                                          *GSDMB*           Epithelial development                                                                                         Alu                 Ape                 Regulatory           Major promoter             Stomach                             Active              Komiyama *et al.*, 2010 \[[@B121]\]
                                                          *HYAL4*           Hyaluronidase                                                                                                  LINE-1/Alu          \>Human             Regulatory           Major promoter             Placenta                            Active              van de Lagemaat *et al.*, 2003 \[[@B73]\]
  Placental oestrogen synthesis                           *HSD17B1*         Oestrogen synthesis                                                                                            ERV                 \>Human             Regulatory           Major promoter             Ovary, placenta                     Active              Cohen *et al.*, 2009 \[[@B122]\]
  Placental development                                   *INSL4*           Regulation of cell growth and metabolism                                                                       ERV                 Old World primate   Regulatory           Major promoter             Placenta                            Active              Bieche *et al.*, 2003 \[[@B123]\]
                                                          *DSCR4*           Unknown reproductive function                                                                                  ERV                 Ape                 Regulatory           Major promoter             Placenta, testis                    Active              Dunn *et al.*, 2006 \[[@B124]\]
                                                          *DSCR8*           Unknown reproductive function                                                                                  ERV                 \>Ape               Regulatory           Major promoter             Placenta, testis                    Active              Dunn *et al.*, 2006 \[[@B124]\]
                                                          *CGA*             Common subunit of chorionic gonadotropin, luteinizing, follicle-stimulating and thyroid-stimulating hormones   Alu                 \>Simian            Regulatory           Negative regulation        Placenta, pituitary gland           Active              Scofield *et al.*, 2000 \[[@B125]\]
  Globin switching                                        *HBE1*            Embryonic oxygen transport                                                                                     Alu                 \>Human             Regulatory           Negative regulation        Fetal                               Active              Wu *et al.*, 1990 \[[@B126]\]
                                                          *GH*              Growth hormone                                                                                                 Alu                 \>Human             Regulatory           Negative regulation        Pituitary gland                     Active              Trujillo *et al.*, 2006 \[[@B127]\]
                                                          *WT1*             Urogenital development                                                                                         Alu                 \>Human             Regulatory           Negative regulation        Urogenital                          Active              Hewitt *et al.*, 1995 \[[@B128]\]
  Efficient placental gas exchange                        *HBG1*            Fetal oxygen transport                                                                                         LINE-1              Old World primate   Regulatory           Tissue-specific enhancer   Fetal                               Active              Johnson *et al.*, 2006 \[[@B91]\]
  Placental leptin secretion                              *LEP*             Metabolic regulatory hormone                                                                                   LTR                 \>Human             Regulatory           Tissue-specific enhancer   Placenta                            Active              Bi *et al.*, 1997 \[[@B129]\]
                                                          *MET*             Hepatocyte growth-factor receptor                                                                              LINE-1              \> Afr. great ape   Regulatory           Alternative promoter       Liver, Pancreas, Lung               Active              Nigumann *et al.*, 2002 \[[@B71]\]
                                                          *BCAS3*           Embryogenesis/erythropoiesis                                                                                   LINE-1              \> Afr. great ape   Regulatory           Alternative promoter       Fetal, various                      Active              Wheelan *et al.*, 2005 \[[@B130]\]
                                                          *CHRM3*           Synaptic transmission                                                                                          LINE-1              Human               Regulatory           Alternative promoter       Placenta                            Active              Huh *et al.*, 2009 \[[@B131]\]
                                                          *CLCN5*           Chloride transporter                                                                                           LINE-1              \>Human             Regulatory           Alternative promoter       Placenta                            Active              Matlik *et al.*, 2006 \[[@B132]\]
                                                          *SLCO1A2*         Organic anion transporter                                                                                      LINE-1              \>Human             Regulatory           Alternative promoter       Placenta                            Active              Matlik *et al.*, 2006 \[[@B132]\]
                                                          *CHRM3*           Synaptic transmission                                                                                          LTR                 Human               Regulatory           Alternative promoter       Testis                              Active              Huh *et al.*, 2009 \[[@B131]\]
                                                          *IL2RB*           Growth-factor receptor                                                                                         LTR                 \>Human             Regulatory           Alternative promoter       Placenta                            Active              Cohen *et al.*, 2009 \[[@B122]\]
  Placental development                                   *ENTPD1*          Thromboregulation                                                                                              LTR                 \>Human             Regulatory           Alternative promoter       Placenta                            Active              van de Lagemaat *et al.*, 2003 \[[@B73]\]
                                                          *MKKS*            Molecular chaperone                                                                                            LTR/LINE-2          \>Human             Regulatory           Alternative promoter       Testis, fetal                       Active              van de Lagemaat *et al.*, 2003 \[[@B73]\]
                                                          *NAIP*            Anti-apoptosis                                                                                                 ERV                 \>Human             Regulatory           Alternative promoter       Testis                              Active              Romanish *et al.*, 2007 \[[@B133]\]
                                                          *EDNRB*           Placental development/circulation                                                                              ERV                 \>Human             Regulatory           Alternative promoter       Placenta                            Active              Medstrand *et al.*, 2001 \[[@B134]\]
  Placental development                                   *PTN*             Growth factor                                                                                                  ERV                 Ape                 Regulatory           Alternative promoter       Trophoblast                         Active              Schulte *et al.*1996 \[[@B135]\]
                                                          *MID1*            Cell proliferation and growth                                                                                  ERV                 Old World primate   Regulatory           Alternative promoter       Placenta, fetal kidney              Active              Landry *et al.*, 2002 \[[@B136]\]
                                                          *NOS3*            Endothelial nitric oxide synthesis                                                                             ERV                 \>Human             Regulatory           Alternative promoter       Placenta                            Active              Huh *et al.*, 2008 \[[@B137]\]
                                                          *GSDMB*           Epithelial development                                                                                         ERV                 Ape                 Regulatory           Alternative promoter       Various                             Active              Sin *et al.*, 2006 \[[@B138]\]
  Placental oestrogen synthesis                           *CYP19*           Oestrogen synthesis                                                                                            ERV                 Simian              Regulatory           Alternative promoter       Placenta                            Active              van de Lagemaat *et al.*, 2003 \[[@B73]\]
                                                          *AMACs*           Fatty-acid synthesis                                                                                           SVA                 Afr. great ape      Retrotransposition   Novel genes                Placenta, testis                    Active              Xing *et al.*, 2006 \[[@B139]\]
                                                          *POTEs*           Pro-apoptosis/spermatogenesis                                                                                  LINE-1              Ape                 Retrotransposition   Novel fusion genes         Testis, ovary, prostate, placenta   Active              Lee *et al.*, 2006 \[[@B140]\]
                                                          *PIPSL*           Intracellular protein trafficking                                                                              LINE-1              \>Great ape         Retrotransposition   Novel fusion gene          Testis                              Active              Babushok *et al.*, 2007 \[[@B141]\]
                                                          *CDYs*            Chromatin modification                                                                                         Unknown             Simian              Retrotransposition   Novel genes                Testis                              Active              Lahn and Page, 1999 \[[@B142]\]
                                                          *ADAM20/21*       Membrane metalloprotease                                                                                       Unknown             \>Human             Retrotransposition   Novel genes                Testis                              Active              Betran and Long, 2002 \[[@B143]\]
  Placental growth hormone secretion                      *GH*              Placental growth hormone                                                                                       Alu                 Simian              Duplication          Novel genes                Placenta                            Passive             De Mendoza *et al.*, 2004 \[[@B88]\]
                                                          *Chr19 miRNAs*    Unknown                                                                                                        Alu                 Simian              Duplication          Novel genes                Placenta                            Passive             Zhang *et al.*, 2008 \[[@B144]\]
  Enhanced immune tolerance at fetal-maternal interface   *LGALS13/14/16*   Carbohydrate recognition/immune regulation                                                                     LINE-1              Simian              Duplication          Novel genes                Placenta                            Passive             Than *et al.*, 2009 \[[@B145]\]
  Efficient placental gas exchange                        *HBG2*            Fetal oxygen transport                                                                                         LINE-1              Simian              Duplication          Novel gene                 Fetal                               Passive             Fitch *et al.*, 1991 \[[@B90]\]

^a^\> = Maximum known distribution.

^b^ERV = endogenous retrovirus

^c^LTR = long terminal repeat

^d^LINE = long interspersed nuclear element

###### 

Specific examples of transposable elements (TEs) implicated in primate-specific traits: immune defence

  TE generated trait                                                            Gene affected   Gene function                                 TE responsible   Distribution^a^            Type of event        Effect                                         Tissue expression                   Type of TE-Thrust   Reference
  ----------------------------------------------------------------------------- --------------- --------------------------------------------- ---------------- -------------------------- -------------------- ---------------------------------------------- ----------------------------------- ------------------- -------------------------------------------
  Soluble CD55                                                                  *CD55*          Complement regulation                         Alu              \>Human                    Exonization          Novel isoform                                  Various                             Active              Caras *et al.*, 1987 \[[@B146]\]
  Intracellular TNFR                                                            *P75TNFR*       Tumour necrosis factor receptor               Alu              Old World primate          Exonization          Novel isoform                                  Various                             Active              Singer *et al.*, 2004 \[[@B147]\]
  Altered infectious-disease resistance?                                        *IRGM*          Intracellular pathogen resistance             ERV^b^           Afr. Great Ape             Regulatory           Major promoter                                 Various                             Active              Bekpen *et al.*, 2009 \[[@B148]\]
  Altered infectious-disease resistance?                                        *IL29*          Antiviral cytokine                            Alu/LTR^c^       \>Human                    Regulatory           Positive regulation                            Dendritic cells, epithelial cells   Active              Thomson *et al.*, 2009 \[[@B149]\]
                                                                                *FCER1G*        IgE/IgG Fc receptor/T cell antigen receptor   Alu              Ape                        Regulatory           Positive/negative regulation                   T cells, basophils                  Active              Brini *et al.*, 1993 \[[@B150]\]
                                                                                *CD8A*          T cell interaction with class I MHC           Alu              Ape                        Regulatory           Tissue-specific enhancer                       T cells                             Active              Hambor *et al.*, 1993 \[[@B151]\]
  Red cell ABH antigen expression                                               *FUT1*          Fucosyltransferase                            Alu              Ape                        Regulatory           Alternative promoter                           Erythrocytes                        Active              Apoil *et al.*, 2000 \[[@B96]\]
                                                                                *TMPRSS3*       Membrane serine protease                      Alu/LTR          \>Human                    Regulatory           Alternative promoter                           Peripheral blood leukocytes         Active              van de Lagemaat *et al.*, 2003 \[[@B73]\]
  Colon Le antigen expression                                                   *B3GALT5*       Galactosyltransferase                         ERV              Old World primate          Regulatory           Alternative promoter                           Colon, small intestine, breast      Active              Dunn *et al.*, 2003 \[[@B152]\]
  Prolactin potentiation of the adaptive immune response                        *PRL*           Regulation of lactation and reproduction      ERV              Old World primate          Regulatory           Alternative promoter                           Lymphocytes, endometrium            Active              Gerlo *et al.*, 2006 \[[@B153]\]
                                                                                *ST6GAL1*       Sialyltransferase                             ERV              \>Human                    Regulatory           Alternative promoter                           B lymphocytes                       Active              van de Lagemaat *et al.*, 2003 \[[@B73]\]
  Vitamin D regulation of cathelicidin antimicrobial peptide gene               *CAMP*          Antimicrobial peptide                         Alu              Simian                     Regulatory           Vitamin D responsiveness                       Myeloid cells, various              Active              Gombart *et al.*, 2009 \[[@B98]\]
                                                                                *MPO*           Myeloperoxidase/microbicidal enzyme           Alu              \>Human                    Regulatory           Thyroid hormone/retinoic acid responsiveness   Myeloid cells                       Active              Piedrafita *et al.*, 1996 \[[@B154]\]
  Altered infectious-disease resistance?                                        *IFNG*          Antiviral/immunoregulatory factor             Alu              Old World primate          Retrotransposition   Novel positive regulatory element              Natural killer cells, T cells       Active              Ackerman *et al.*, 2002 \[[@B155]\]
  Absence of N-glycolylneuraminic acid/altered infectious-disease resistance?   *CMAH*          *N*-glycolylneuraminic acid synthesis         Alu              Human                      Gene disruption      Gene loss                                      Various                             Active              Hayakawa *et al.*, 2001 \[[@B104]\]
                                                                                *IRGM*          Intracellular pathogen resistance             Alu              Old and New World monkey   Gene disruption      Gene loss                                      Various                             Active              Bekpen *et al.*, 2009 \[[@B148]\]
  Altered malaria resistance?                                                   *HBA2*          Oxygen transport                              Alu              \>Ape                      Duplication          Novel gene                                     Erythrocytes                        Passive             Hess *et al.*, 1983 \[[@B156]\]

^a^\> = Maximum known distribution.

^b^ERV = endogenous retrovirus

^c^LTR = long terminal repeat

###### 

Specific Examples of transposable elements (TEs) implicated in primate-specific traits: metabolic and other

  TE generated trait                                        Gene affected   Gene function                              TE responsible      Distribution^a^              Type of event        Effect                            Tissue expression                              Type of TE-Thrust   Reference
  --------------------------------------------------------- --------------- ------------------------------------------ ------------------- ---------------------------- -------------------- --------------------------------- ---------------------------------------------- ------------------- -------------------------------------------
                                                            *RNF19A*        Ubiquitin ligase                           Alu                 \> Human                     Exonization          Novel isoform                     Various                                        Active              Huh *et al.*, 2008 \[[@B157]\]
                                                            *BCL2L11*       Pro-apoptotic                              Alu                 \> Human                     Exonization          Novel isoform                     Various                                        Active              Wu *et al.*, 2007 \[[@B158]\]
                                                            *BCL2L13*       Pro-apoptotic                              Alu                 \> Human                     Exonization          Novel isoform                     Various (cytosolic instead of mitochondrial)   Active              Yi *et al.*, 2003 \[[@B159]\]
                                                            *SFTPB*         Pulmonary surfactant                       Alu/ERV^b^          Primate                      Exonization          Novel isoform                     Various                                        Active              Lee *et al.*, 2009 \[[@B160]\]
  Efficiency of ZNF177 transcription and translation        *ZNF177*        Transcriptional regulator                  Alu/LINE-1^c^/ERV   \> Human                     Exonization          Novel isoform                     Various                                        Active              Landry *et al.*, 2001 \[[@B161]\]
  Production of salivary amylase                            *AMY1s*         Starch digestion                           ERV                 Old World primate            Regulatory           Major promoter                    Salivary gland                                 Active              Ting *et al.*, 1992 \[[@B99]\]
                                                            *BAAT*          Bile metabolism                            ERV                 \> Human                     Regulatory           Major promoter                    Liver                                          Active              van de Lagemaat *et al.*, 2003 \[[@B73]\]
                                                            *CETP*          Cholesterol metabolism                     Alu                 \> Human                     Regulatory           Negative regulation               Liver                                          Active              Le Goff *et al.*, 2003 \[[@B162]\]
  Absence of FMO1 in adult liver/altered drug metabolism?   *FMO1*          Xenobiotic metabolism                      LINE-1              \> Human                     Regulatory           Negative regulation in liver      Kidney                                         Active              Shephard *et al.*, 2007 \[[@B163]\]
                                                            *RNF19A*        Ubiquitin ligase                           LTR^d^              \> Human                     Regulatory           Alternative promoter              Various                                        Active              Huh *et al.*, 2008 \[[@B157]\]
                                                            *APOC1*         Lipid metabolism                           ERV                 Ape                          Regulatory           Alternative promoter              Various                                        Active              Medstrand *et al.*, 2001 \[[@B134]\]
                                                            *KRT18*         Epithelial keratin                         Alu                 \> Human                     Regulatory           Retinoic acid responsiveness      Various                                        Active              Vansant and Reynolds, 1995 \[[@B77]\]
                                                            *PTH*           Parathyroid hormone                        Alu                 \> Old World primate         Regulatory           Negative calcium responsiveness   Parathyroid gland                              Active              McHaffie and Ralston, 1995 \[[@B164]\]
                                                            *PRKACG*        cAMP signalling/regulation of metabolism   Unknown             \> Old World primate         Retrotransposition   Novel gene                        Various                                        Active              Reinton *et al.*, 1998 \[[@B165]\]
                                                            *NBR2*          Unknown                                    Alu                 Old World primate            Duplication          Novel gene                        Various                                        Passive             Jin *et al.*, 2004 \[[@B166]\]
                                                            *LRRC37A*       Unknown                                    Alu                 Old World primate            Duplication          Novel genes                       Various                                        Passive             Jin *et al.*, 2004 \[[@B166]\]
                                                            *ARF2*          GTPase/vesicle trafficking                 Alu                 Great ape                    Inversion            Novel fusion gene                 Various                                        Passive             Jin *et al.*, 2004 \[[@B166]\]
  Altered arterial wall function?                           *ELN*           Elastin                                    Alu                 \> Old World primate/human   Deletion             Exon losses                       Various                                        Passive             Szabo *et al.*, 1999 \[[@B167]\]
  Low body mass?                                            *ASIP*          Energy metabolism/pigmentation             Alu                 Lesser ape (gibbon)          Deletion             Gene loss                         Various                                        Passive             Nakayama and Ishida, 2006 \[[@B101]\]

^a^\> = Maximum known distribution.

^b^ERV = endogenous retrovirus

^c^LINE = long interspersed nuclear element

^d^LTR = long terminal repeat

L1 and the primate-specific Alu predominate in simians \[[@B21],[@B40],[@B41]\], and thus strongly contribute to TE-Thrust in this lineage (Figure [1A](#F1){ref-type="fig"}). The autonomous L1 is almost universal in mammals, whereas the non-autonomous Alu, like most SINEs, is conspicuously lineage-specific, having been synthesized *de novo*, extremely unusually, from a 7SL RNA-encoding gene. The confinement of Alu to a single mammalian order is typical of younger SINEs, whereas ancient SINEs, or exapted remnants of them, may be detectable across multiple vertebrate classes \[[@B43]\]. Alu possesses additional unusual characteristics: extreme abundance (1.1 million copies, occurring every 3 kb on average in the human genome), frequent location in gene-rich regions, and a lack of evolutionary divergence \[[@B21],[@B44]\]. Their relatively high homology is most easily explained as being the result of functional selection helping to prevent mutational drift. Thus, Alus have been hypothesized to serve biological functions in their own right, leading to their selection and maintenance in the primate genome \[[@B22]\]. For example, A-to-I RNA editing, which has a very high prevalence in the human genome, mainly occurs within Alu elements \[[@B45]\], which would seem to provide primates with a genetic sophistication beyond that of other mammals. Alus may therefore not represent a peculiar, evolutionary neutral invasion, but rather positively selected functional elements that are resistant to mutational degradation \[[@B46]\]. This has significance for TE-Thrust, as it would greatly prolong the usefulness of Alus as facilitators of evolution within primate lineages.

Other human retro-TEs include the fossil tRNA mammalian-wide intespersed repeat (MIR) SINE, which amplified approximately 130 Mya \[[@B21],[@B47]\] and the much younger SVA, a non-autonomous composite element partly derived from ERV and Alu sequences, which is specific to the great apes and humans \[[@B48]\]. Like Alus, SVAs are mobilised by L1-encoded enzymes and, similar to Alu, a typical full-length SVA is GC-rich, and thus constitutes a potential mobile CpG island. Importantly, ERVs are genome builders/modifiers of exogenous origin \[[@B49]\]. Invasion of ERVs seems to be particularly associated with a key mammalian innovation, the placenta (Table [4](#T4){ref-type="table"}). The endogenisation of retroviruses and the horizontal transfer of DNA-TEs into germlines clearly show that the Weismann Barrier is permeable, contrary to traditional theory.

The DNA-TEs, which comprise just 3% of the human genome, are extremely diverse, but are now completely inactive \[[@B21],[@B50]\]. Although some have been exapted within the simian lineage as functional coding sequences (Table [3](#T3){ref-type="table"}; Table [4](#T4){ref-type="table"}; Table [5](#T5){ref-type="table"}; Table [6](#T6){ref-type="table"}), DNA-TEs, it seems, cannot now be a significant factor for TE-Thrust in primates, unless there are new infiltrations.

TE-Thrust influences evolutionary trajectories
==============================================

A key proposal of our TE-Thrust hypothesis is that TEs can promote the origin of new lineages and drive lineage divergence through the engineering of specific traits. Ancestral TEs shared across very many lineages can, by chance, lead to the delayed generation of traits in one lineage but not in another. For example, more than 100 copies of the ancient amniote-distributed AmnSINE1 are conserved as non-coding elements specifically among mammals \[[@B51]\]. However, as they often show a narrow lineage specificity, we hypothesize that younger SINEs (with their partner LINEs) may have a large influence upon the trajectory and the outcomes of the evolution within clades, as is apparent with the Alu/L1 pair in primates (Figure [1A](#F1){ref-type="fig"}). Probably not all SINEs are equal in this ability; it seems that some SINEs are more readily mobilised than others, and when mobilised, some SINEs are more effective than others at facilitating evolution by TE-Thrust. The extremely abundant primate Alu dimer seems to illustrate this. Whereas the overwhelming majority of SINEs are derived from tRNAs, Alus may have proliferated so successfully because they are derived from the 7SL RNA gene \[[@B52]\], which is part of the signal recognition particle (SRP) that localises to ribosomes. Alu RNAs can therefore bind proteins on the SRP and thus be retained on the ribosome, in position to be retrotransposed by newly synthesized proteins encoded by their partner L1 LINEs \[[@B53]\].

Among the primates, the simians have undergone the greatest evolutionary transitions and radiation. Of the approximately 367 extant primate species, 85% are simians, with the remainder being prosimians, which diverged about 63 Mya. Significantly, large amplifications of L1, and thus of Alus and other sequences confined to simians, offer a plausible explanation for the lack of innovation in the trajectory of evolution in the prosimian lineages, compared with the innovation in the simian lineages. Since their divergence from the basal primates, the simians have experienced repeated periods of intense L1 activity that occurred from about 40 Mya to about 12 Mya \[[@B54]\]. The highly active simian L1s were responsible for the very large amplification of younger Alus and of many gene retrocopies \[[@B55]\]. Possibly, differential activity of the L1/Alu pair may have driven the trajectory and divergence of the simians, compared with the prosimians. The greater endogenization of some retroviruses in simians compared with prosimians \[[@B56]\] may also have played a part. These events may also explain the larger genome size of the simians compared with prosimians \[[@B57]\].

A significant feature of Alus is their dimeric structure, involving a fusion of two slightly dissimilar arms \[[@B58]\]. This added length and complexity seems to increase their effectiveness as a reservoir of evolutionarily useful DNA sequence or as an inducer of ectopic recombination. It may therefore be no coincidence that simian genomes are well endowed with dimeric Alus. Viable SINEs in the less fecund and less evolutionary innovative prosimians are heterogeneous, and include the conventional dimeric Alu, Alu-like monomers, Alu/tRNA dimers and tRNA SINEs \[[@B59]\]. This distinctly contrasts with simian SINEs; in simians, viable SINEs are almost entirely dimeric Alus. Thus, both qualitatively and quantitatively, the Alu dimer seems to represent a key example of the power of a SINE to strongly influence evolutionary trajectory.

Although these coincident events cannot, by themselves, be a clear indication of cause and effect, distinct Alu subfamilies (*AluJ, AluS, AluY*) correlate with the divergence of simian lineages \[[@B38],[@B39]\]. Whereas the *AluJ*subfamily was active about 65 Mya when the separation and divergence between the simians and the prosimians occurred, the *AluS*subfamily was active beginning at about 45 Mya, when the Old World monkey proliferation occurred, followed by a surge in *AluY*activity and expansion beginning about 30 Mya, contemporaneous with the split between apes and Old World monkeys \[[@B38],[@B39]\]. Thus, periodic expansions of Alu subfamilies in particular seem to correspond temporally with major divergence points in primate evolution. More recent Alu activity may be a factor in the divergence of the human and chimpanzee lineages, with Alus having been three times more active in humans than in chimpanzees \[[@B40],[@B60]\]. Moreover, at least two new Alu subfamilies (*AluYa5*and *AluYb8*) have amplified specifically within the human genome since the human-chimpanzee split \[[@B40],[@B60],[@B61]\].

Passive TE-Thrust mediated by the Alu/L1 pair has also been evident as a force contributing to lineage divergence in the primates. Ectopic recombinations between Alus, in particular, are a frequent cause of lineage-specific deletion, duplication or rearrangement. Comparisons between the human and chimpanzee genomes have revealed the extent to which they have passively exerted their effects in the relatively recent evolutionary history of primates. An examination of human-specific Alu recombination-mediated deletion (ARMD) identified 492 ARMD events responsible for the loss of about 400 kb of sequence in the human genome \[[@B62]\]. Likewise, Han *et al.*\[[@B63]\] reported 663 chimpanzee-specific ARMD events, deleting about 771 kb of genomic sequence, including exonic sequences in six genes. Both studies suggested that ARMD events may have contributed to the genomic and phenotypic diversity between chimpanzees and humans. L1-mediated recombination also seems to be a factor in primate evolution, with Han *et al.*\[[@B64]\] reporting 50 L1-mediated deletion events in the human and chimpanzee genomes. The observed high enrichment of TEs such as Alu at low-copy-repeat junctions indicates that TEs have been an important factor in the generation of segmental duplications that are uniquely abundant in primate genomes \[[@B39]\]. Such genomic duplications provide a major avenue for genetic innovation by allowing the functional specialization of coding or regulatory sequences. Karyotypic changes are thought to be an important factor in speciation \[[@B65]\]. Major differences between the human and chimpanzee genomes include nine pericentric inversions, and these have also been linked to TE-mediated recombination events \[[@B66]\]. It thus seems that both the active and passive effects of Alu and L1 have greatly facilitated and influenced the trajectory of simian evolution by TE-Thrust. Transfer RNA-type SINEs, with suitable partner LINEs, probably perform this role in other lineages.

TE-Thrust affects evolutionary trajectory by engineering lineage-specific traits
================================================================================

TEs can act to generate genetic novelties and thus specific phenotypic traits in numerous ways. Besides passively promoting exon, gene or segmental duplications (or deletions) by unequal recombination, or by disruption of genes via insertion, TEs can actively contribute to gene structure or regulation via exaptation. On multiple occasions, TEs have been domesticated to provide the raw material for entire genes or novel gene fusions \[[@B11]\]. More frequently, TEs have contributed partially to individual genes through exonization after acquisition of splice sites \[[@B67],[@B68]\]. Independent exons generated by TEs are often alternatively spliced, and thereby result in novel expressed isoforms that increase the size of the transcriptome \[[@B69]\]. The generation of novel gene sequences during evolution seems to be heavily outweighed by genetic or epigenetic changes in the transcriptional regulation of pre-existing genes \[[@B34],[@B70]\]. Consistent with this, much evidence indicates that a major way in which TEs have acted to functionally modify primate genomes is by actively inserting novel regulatory elements adjacent to genes, thus silencing or enhancing expression levels or changing expression patterns, often in a tissue-specific manner \[[@B71]-[@B73]\]. Moreover, because they are highly repetitious and scattered, TEs have the capacity to affect gene expression on a genome-wide scale by acting as distributors of regulatory sequences or CpG islands in a modular form \[[@B74]\]. Many functional binding sites of developmentally important transcription factors have been found to reside on Alu repeats \[[@B75]\]. These include oestrogen receptor-dependent enhancer elements \[[@B76]\] and retinoic acid response elements, which seem to have been seeded next to retinoic acid target genes throughout the primate genome by the *AluS*subfamily \[[@B77]\]. As a consequence, TEs are able to contribute significantly to the species-specific rewiring of mammalian transcriptional regulatory networks during pre-implantation embryonic development \[[@B78]\]. Similarly, primate-specific ERVs have been implicated in shaping the human p53 transcriptional network \[[@B79]\] and rewiring the core regulatory network of human embryonic stem cells \[[@B80]\].

Certain classes of retro-TEs can actively generate genetic novelty using their retrotranspositional mechanism to partially or fully duplicate existing cellular genes. Duplication is a crucial aspect of evolution, which has been particularly important in vertebrates, and constitutes the primary means by which organisms evolve new genes \[[@B81]\]. LINEs and SVAs have a propensity to transduce host DNA due to their weak transcriptional termination sites, so that 3\' flanking regions are often included in their transcripts. This can lead to gene duplication, exon shuffling or regulatory-element seeding, depending on the nature of the sequence involved \[[@B37],[@B82],[@B83]\]. Duplication of genes can also occur via the retrotransposition of mRNA transcripts by LINEs. Such genes are termed retrocopies, which, after subsequent useful mutation, can sometimes evolve into retrogenes, with a new, related function. There are reportedly over one thousand transcribed retrogenes in the human genome \[[@B84]\], with about one new retrogene per million years having emerged in the human lineage during the past 63 Myr \[[@B26]\]. Some primate retrogenes seem to have evolved highly beneficial functions, such as *GLUD2*\[[@B37]\].

Specific evidence for TE-Thrust: examples of traits engineered by TEs in the higher primates
============================================================================================

TEs seem to have heavily influenced the trajectories of primate evolution and contributed to primate characteristics, as the simians in particular have undergone major evolutionary advancements in cognitive ability and physiology (especially reproductive physiology). The advancement and radiation of the simians seems to be due, in part and all else being equal, to exceptionally powerful TE-Thrust, owing to its especially effective Alu dimer, partnered by very active novel L1 families, supplemented by ERVs and LTRs. These have engineered major changes in the genomes of the lineage(s) leading to the simian radiations and major transitions. We identified more than 100 documented instances in which TEs affected individual genes and thus were apparently implicated at a molecular level in the origin of higher primate-specific traits (Table [3](#T3){ref-type="table"}; Table [4](#T4){ref-type="table"}; Table [5](#T5){ref-type="table"}; Table [6](#T6){ref-type="table"}). The Alu SINE dominated, being responsible for nearly half of these cases, with ERVs/sLTRs being responsible for a third, followed by L1-LINEs at 15% (Figure [1A](#F1){ref-type="fig"}). Just 2% were due to the young SVAs, and 1% each to ancient MIR SINEs and DNA-TEs. More than half the observed changes wrought by TEs were regulatory (Figure [1B](#F1){ref-type="fig"}). As discussed below, TEs seem to have influenced four main aspects of the primate phenotype: brain and sensory function, reproductive physiology, immune defence, and metabolic/other (Figure [1C](#F1){ref-type="fig"} and Table [3](#T3){ref-type="table"}; Table [4](#T4){ref-type="table"}; Table [5](#T5){ref-type="table"}; Table [6](#T6){ref-type="table"}). Notably, ERVs, which are often highly transcribed in the germline and placenta \[[@B85]\], were strongly associated with reproductive traits, whereas Alus influenced these four aspects almost equally (Figure [2](#F2){ref-type="fig"}).

![**Comparison of aspects of primate phenotype affected by **(A)**Alu elements and **(B)**LTR/ERVs. Based on the published data shown in Tables 3 to 6**.](1759-8753-2-8-2){#F2}

Brain and sensory function
--------------------------

The large brain, advanced cognition and enhanced colour vision of higher primates are distinct from those of other mammals. The molecular basis of these characteristics remains to be fully defined, but from evidence already available, TEs (particularly Alus) seem to have contributed substantially via the origination of novel genes and gene isoforms, or via altered gene transcription (Table [3](#T3){ref-type="table"}). Most of the neuronal genes affected by TEs are restricted to the apes, and they seem to have roles in synaptic function and plasticity, and hence learning and memory. These genes include multiple neurotransmitter receptor genes and *glutamate dehydrogenase 2*(*GLUD2)*, a retrocopy of *GLUD1*that has acquired crucial point mutations. *GLUD2*encodes glutamate dehydrogenase, an enzyme that seems to have increased the cognitive powers of the apes through the enhancement of neurotransmitter recycling \[[@B37]\]. The cell cycle-related kinase (*CCRK*) gene represents a good example of how the epigenetic modification of TEs can be mechanistically linked to the transcriptional regulation of nearby genes \[[@B86]\]. In simians, this gene possesses regulatory CpGs contained within a repressor Alu element, and these CpGs are more methylated in the cerebral cortex of human compared with chimpanzee. Concordantly, *CCRK*is expressed at higher levels in the human brain \[[@B86]\]. TEs may also affect the brain at a somatic level, because embryonic neural progenitor cells have been found to be permissive to L1 activity in humans \[[@B87]\]. This potentially provides a mechanism for increasing neural diversity and individuality. As our human lineage benefits from a diversity of additional individual talents, as well as shared talents, this phenomenon, if confirmed, could increase the \'fitness\' of the human lineage, and is entirely consistent with the concept of differential survival of lineages, as stated in our TE-Thrust hypothesis.

The trichromatic vision of Old World monkeys and apes immensely enhanced their ability to find fruits and other foods, and probably aided them in group identity. This trait evidently had its origin in an Alu-mediated gene-duplication event that occurred about 40 Mya, and subsequently resulted in two separate cone photoreceptor (opsin) genes \[[@B36]\], the tandem *OPN1LW*and *OPN1MW*, which are sensitive to long- and medium-wave light respectively. Other mammals possess only dichromatic vision.

Reproductive physiology
-----------------------

Compared with other mammals, simian reproduction is characterized by relatively long gestation periods and by the existence of a hemochorial-type placenta that has evolved additional refinements to ensure efficient fetal nourishment. Available data suggests that TE-Thrust has contributed much of the uniqueness of the higher primate placenta, which seems to be more invasive than that of other mammals, and releases a large number of factors that modify maternal metabolism during pregnancy. These characteristics appear to be due to the generation of novel placenta genes and to various TEs having been exapted as regulatory elements to expand or enhance the expression of pre-existing mammalian genes in the primate placenta (Table [4](#T4){ref-type="table"}). The growth hormone (*GH*) gene locus is particularly notable for having undergone rapid evolution in the higher primates compared with most other mammals. A crucial aspect of this evolutionary advance was a burst of gene-duplication events in which Alu-mediated recombination is implicated as a driving force \[[@B88]\]. The simians thus possess between five and eight *GH*gene copies, and these show functional specialization, being expressed in the placenta, in which they are thought to influence fetal access to maternal resources during pregnancy \[[@B88],[@B89]\]. Longer gestation periods in simians were accompanied by adaptations to ensure an adequate oxygen supply. One key event was an L1-mediated duplication of the *HBG*globin gene in the lineage leading to the higher primates, which generated *HBG1*and *HBG2*\[[@B90]\]. *HBG2*subsequently acquired expression specifically in the simian fetus, in which it ensures the high oxygen affinity of fetal blood for more efficient oxygen transfer across the placenta. Old World primates additionally express *HBG1*in the fetus, owing to an independent LINE insertion at the beta globin locus \[[@B91]\]. Thus, the important process of placental gas exchange has been extensively improved by TEs in simians, in contrast to that of many mammals, including prosimians, in which fetal and adult haemoglobins are the same.

Two prominent examples of functionally exapted genes whose sequences are entirely TE-derived are *syncytin-1*(*ERVWE1*) and *syncytin-2*(*ERVWE2*). Both of these primate-specific genes are derived from ERV envelope (*env*) genes \[[@B92],[@B93]\]. The syncytins play a crucial role in simian placental morphogenesis by mediating the development of the fetomaternal interface, which has a fundamental role in allowing the adequate exchange of nutrients and other factors between the maternal bloodstream and the fetus. In a remarkable example of convergent evolution, which attests to the importance of this innovation, two ERV *env*genes, *syncytin*-*A*and *syncytin*-*B*, independently emerged in the rodent lineage about 20 Mya \[[@B94]\], as did *syncytin-Ory1*within the lagomorphs 12-30 Mya, and these exhibit functional characteristics analogous to the primate syncytin genes \[[@B95]\]. This example, as well as many others (Table [3](#T3){ref-type="table"}; Table [4](#T4){ref-type="table"}; Table [5](#T5){ref-type="table"}; Table [6](#T6){ref-type="table"}) suggests the possibility that TE-Thrust may be an important factor in convergent evolution, a phenomenon that can be difficult to explain by traditional theories.

Immune defence
--------------

Immune-related genes were probably crucial to the primate lineage by affording protection from potentially lethal infectious diseases. TEs have been reported to contribute to higher primate-restricted transcripts, or to the expression of a wide variety of immunologically relevant genes (Table [5](#T5){ref-type="table"}). One example is the insertion of an AluY element into intron 1 of the fucosyltransferase (*FUT*)*1*gene in an ancestor of humans and apes. This enabled erythrocytic expression of *FUT1*, and thus the ABO blood antigens \[[@B96]\], an adaptation linked to the selective pressure by malarial infection \[[@B97]\]. A particularly good example of a primate-specific adaptation that can be accounted for by a TE is the regulation of the cathelicidin antimicrobial peptide (*CAMP*) gene by the vitamin D pathway. Only simians possess a functional vitamin D response element in the promoter of this gene, which is derived from the insertion of an AluSx element. This genetic alteration enhances the innate immune response of simians to infection, and potentially counteracts the anti-inflammatory properties of vitamin D \[[@B98]\].

Metabolic/other
---------------

TEs seem to underlie a variety of other primate adaptations, particularly those associated with metabolism (Table [6](#T6){ref-type="table"}). A striking example, related to dietary change, was the switching of the expression of certain α-amylase genes (*AMY1A, AMY1B*and *AMY1C*) from the pancreas to the salivary glands of Old World primates. This event, which was caused by the genomic insertion of an ERV acting as a tissue-specific promoter \[[@B99]\], facilitated the utilization of a higher starch diet in some Old World primates. This included the human lineage, in which consumption of starch became increasingly important, as evidenced by the average human having about three times more *AMY1*gene copies than chimpanzees \[[@B100]\]. Another example was the loss of a 100 kb genomic region in the gibbons, due to homologous recombination between AluSx sites \[[@B101]\], resulting in gibbons lacking the *ASIP*gene involved in the regulation of energy metabolism and pigmentation, which may help to account for their distinctive low body mass, so beneficial for these highly active arboreal primates.

TE-Thrust and divergence of the human lineage
=============================================

Human and chimpanzee genomes exhibit discernable differences in terms of TE repertoire, TE activity and TE-mediated recombination events \[[@B21],[@B40],[@B54],[@B60]-[@B64]\]. Thus, although nucleotide substitutions to crucial genes are important \[[@B31]\], TE-Thrust is likely to have made a significant contribution to the relatively recent divergence of the human lineage \[[@B102],[@B103]\]. In support of this, at least eight of the examples listed (Table [3](#T3){ref-type="table"}; Table [4](#T4){ref-type="table"}; Table [5](#T5){ref-type="table"}; Table [6](#T6){ref-type="table"}) are unique to humans. A notable example of a human-specific TE-mediated genomic mutation was the disruption of the *CMAH*gene, which is involved in the synthesis of a common sialic acid (Neu5Gc), by an AluY element over 2 Mya \[[@B104]\]. This may have conferred on human ancestors a survival advantage by decreasing infectious risk from microbial pathogens known to prefer Neu5Gc as a receptor.

Conclusions
===========

A role for TEs in evolution has long been recognized by many, yet its importance has probably been underestimated. Using primates as exemplar lineages, we have assessed specific evidence, and conclude that it points strongly to an instrumental role for TEs, via TE-Thrust, in engineering the divergence of the simian lineage from other mammalian lineages. TEs, particularly Alu SINEs, have essentially acted as a huge primate-restricted stockpile of potential exons and regulatory regions, and thereby have provided the raw material for these evolutionary transitions. TEs, including Alu SINEs, L1 LINEs, ERVs and LTRs have, through active TE-Thrust, contributed directly to the primate transcriptome, and even more significantly by providing regulatory elements to alter gene expression patterns. Via passive TE-Thrust, homologous Alu and L1 elements scattered throughout the simian genome have led to both genomic gain, in the form of segmental and gene duplications, and genomic loss, by promoting unequal recombination events. Collectively, these events seem to have heavily influenced the trajectories of primate evolution and contributed to characteristic primate traits, as the simian clades especially have undergone major evolutionary advancements in cognitive ability and physiology. Although as yet incompletely documented, the evidence presented here supports the hypothesis that TE-Thrust may be a pushing force for numerous advantageous features of higher primates. These very beneficial features apparently include enhanced brain function, superior fetal nourishment, valuable trichromatic colour vision, improved metabolism, and resistance to infectious-disease agents. Such large evolutionary benefits to various primate clades, brought about by various TE repertories, powerfully demonstrate that if TEs are \'junk\' DNA then there is indeed much treasure in the junkyard, and that the TE-Thrust hypothesis could become an important part of some future paradigm shift in evolutionary theory.
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